These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 37852260)

  • 1. Molecular basis of anaphylatoxin binding, activation, and signaling bias at complement receptors.
    Yadav MK; Maharana J; Yadav R; Saha S; Sarma P; Soni C; Singh V; Saha S; Ganguly M; Li XX; Mohapatra S; Mishra S; Khant HA; Chami M; Woodruff TM; Banerjee R; Shukla AK; Gati C
    Cell; 2023 Oct; 186(22):4956-4973.e21. PubMed ID: 37852260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revealing the signaling of complement receptors C3aR and C5aR1 by anaphylatoxins.
    Wang Y; Liu W; Xu Y; He X; Yuan Q; Luo P; Fan W; Zhu J; Zhang X; Cheng X; Jiang Y; Xu HE; Zhuang Y
    Nat Chem Biol; 2023 Nov; 19(11):1351-1360. PubMed ID: 37169960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decoding anaphylatoxins: unveiling the molecular mechanisms of complement receptor activation and signaling.
    Fernández FJ; Vega MC
    Trends Biochem Sci; 2024 Apr; 49(4):280-282. PubMed ID: 38233283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Anaphylatoxin Receptor Expression and C3a/C5a Functions in Anaphylatoxin Receptor Reporter Mice.
    Laumonnier Y; Karsten CM; Köhl G; Köhl J
    Curr Protoc Immunol; 2020 Sep; 130(1):e100. PubMed ID: 32710701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Complement C3a and C5a Signaling in Renal Diseases: A Bridge between Acute and Chronic Inflammation.
    Buelli S; Imberti B; Morigi M
    Nephron; 2024; 148(10):712-723. PubMed ID: 38452744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In response to complement anaphylatoxin peptides C3a and C5a, human vascular endothelial cells migrate and mediate the activation of B-cells and polarization of T-cells.
    Shivshankar P; Li YD; Mueller-Ortiz SL; Wetsel RA
    FASEB J; 2020 Jun; 34(6):7540-7560. PubMed ID: 32301538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of Complement C3a and C5a receptors Does Not Prevent Angiotensin II-Induced Hypertension and Hypertensive End-Organ Damage.
    Bode M; Herrnstadt GR; Dreher L; Ehnert N; Kirkerup P; Lindenmeyer MT; Meyer-Schwesinger CF; Ehmke H; Köhl J; Huber TB; Krebs CF; Steinmetz OM; Wiech T; Wenzel UO
    Hypertension; 2024 Jan; 81(1):138-150. PubMed ID: 37909169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimeric receptors of the human C3a receptor and C5a receptor (CD88).
    Crass T; Ames RS; Sarau HM; Tornetta MA; Foley JJ; Köhl J; Klos A; Bautsch W
    J Biol Chem; 1999 Mar; 274(13):8367-70. PubMed ID: 10085065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Complement C3a
    Ren W; Liu Y; Wang X; Piao C; Ma Y; Qiu S; Jia L; Chen B; Wang Y; Jiang W; Zheng S; Liu C; Dai N; Lan F; Zhang H; Song WC; Du J
    J Immunol; 2018 Mar; 200(5):1829-1838. PubMed ID: 29367209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaphylatoxin receptor promiscuity for commonly used complement C5a peptide agonists.
    Li XX; Clark RJ; Woodruff TM
    Int Immunopharmacol; 2021 Nov; 100():108074. PubMed ID: 34454293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct and shared roles of β-arrestin-1 and β-arrestin-2 on the regulation of C3a receptor signaling in human mast cells.
    Vibhuti A; Gupta K; Subramanian H; Guo Q; Ali H
    PLoS One; 2011 May; 6(5):e19585. PubMed ID: 21589858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.
    Gu H; Fisher AJ; Mickler EA; Duerson F; Cummings OW; Peters-Golden M; Twigg HL; Woodruff TM; Wilkes DS; Vittal R
    FASEB J; 2016 Jun; 30(6):2336-50. PubMed ID: 26956419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct roles of the anaphylatoxins C3a and C5a in dendritic cell-mediated allergic asthma.
    Engelke C; Wiese AV; Schmudde I; Ender F; Ströver HA; Vollbrandt T; König P; Laumonnier Y; Köhl J
    J Immunol; 2014 Dec; 193(11):5387-401. PubMed ID: 25355927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct roles of the anaphylatoxin receptors C3aR, C5aR1 and C5aR2 in experimental meningococcal infections.
    Muenstermann M; Strobel L; Klos A; Wetsel RA; Woodruff TM; Köhl J; Johswich KO
    Virulence; 2019 Dec; 10(1):677-694. PubMed ID: 31274379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells.
    Monsinjon T; Gasque P; Chan P; Ischenko A; Brady JJ; Fontaine MC
    FASEB J; 2003 Jun; 17(9):1003-14. PubMed ID: 12773483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement c3a and c5a induce different signal transduction cascades in endothelial cells.
    Schraufstatter IU; Trieu K; Sikora L; Sriramarao P; DiScipio R
    J Immunol; 2002 Aug; 169(4):2102-10. PubMed ID: 12165538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1 upregulates anaphylatoxin receptors on mononuclear cells.
    Takabayashi T; Shimizu S; Clark BD; Beinborn M; Burke JF; Gelfand JA
    Surgery; 2004 May; 135(5):544-54. PubMed ID: 15118592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice.
    Schäfer B; Piliponsky AM; Oka T; Song CH; Gerard NP; Gerard C; Tsai M; Kalesnikoff J; Galli SJ
    J Allergy Clin Immunol; 2013 Feb; 131(2):541-8.e1-9. PubMed ID: 22728083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C3a(desArg) does not bind to and signal through the human C3a receptor.
    Wilken HC; Götze O; Werfel T; Zwirner J
    Immunol Lett; 1999 Apr; 67(2):141-5. PubMed ID: 10232396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting C3a/C5a receptors inhibits human mesangial cell proliferation and alleviates immunoglobulin A nephropathy in mice.
    Zhang Y; Yan X; Zhao T; Xu Q; Peng Q; Hu R; Quan S; Zhou Y; Xing G
    Clin Exp Immunol; 2017 Jul; 189(1):60-70. PubMed ID: 28295247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.